Journal For Clinical Studies
Journal For Clinical Studies

SEARCH

MEDIA PACK
NEWS

MENU

Current Edition

 
divestment

Novartis CEO Narashimhan confirms interest in purchase of generics unit Sandoz

Amid Novartis’ strategic review of generics unit Sandoz, last month came word that Swedish investment group EQT and the Struengmann brothers of Germany were considering …

13 December 2021 Regional News divestment generics
Continue Reading →
biotechnology

A Guide for Establishing and Governing Data Collection Standards

Many data management teams report that their standards initiatives have stalled or failed because executives aren’t bought-in, standards are over-proliferated, or they are stuffed with …

9 December 2021 Volume 13 Issue 6 biotechnology clinical data
Continue Reading →
divestment

Novartis may have a buyer for $21B generics unit Sandoz

Amid the industrywide push by Big Pharmas to spin off their generics and consumer businesses, Novartis may be on the verge of separating itself from …

24 November 2021 Regional News divestment generics
Continue Reading →
 
jcs-white

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Twitter Linkedin
Journal For Clinical Studies © 2022, All Rights Reserved – Powered by Teksyte